BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,065 filers reported holding BAXTER INTL INC in Q2 2019. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $456,000 | -32.3% | 5,448 | -29.3% | 0.18% | -8.7% |
| Q3 2019 | $674,000 | +15.8% | 7,702 | +8.3% | 0.20% | +13.4% |
| Q2 2019 | $582,000 | -10.2% | 7,111 | -10.8% | 0.17% | -1.1% |
| Q1 2019 | $648,000 | +15.9% | 7,971 | -6.1% | 0.17% | +4.2% |
| Q4 2018 | $559,000 | -43.6% | 8,491 | -33.9% | 0.17% | +28.5% |
| Q3 2018 | $991,000 | -1.0% | 12,852 | -5.2% | 0.13% | -7.8% |
| Q2 2018 | $1,001,000 | +15.6% | 13,558 | +1.8% | 0.14% | +7.6% |
| Q1 2018 | $866,000 | +5.1% | 13,312 | +4.5% | 0.13% | +17.0% |
| Q4 2017 | $824,000 | +15.4% | 12,742 | +11.9% | 0.11% | +4.7% |
| Q3 2017 | $714,000 | +6.7% | 11,386 | +3.1% | 0.11% | -0.9% |
| Q2 2017 | $669,000 | +17.4% | 11,043 | +0.4% | 0.11% | +13.7% |
| Q1 2017 | $570,000 | +17.0% | 10,995 | +0.1% | 0.10% | +9.2% |
| Q4 2016 | $487,000 | -7.9% | 10,983 | -1.2% | 0.09% | -13.0% |
| Q3 2016 | $529,000 | -6.7% | 11,119 | -11.3% | 0.10% | -9.1% |
| Q2 2016 | $567,000 | +11.2% | 12,530 | +1.0% | 0.11% | +1.9% |
| Q1 2016 | $510,000 | +7.8% | 12,410 | +0.1% | 0.11% | +9.1% |
| Q4 2015 | $473,000 | +17.4% | 12,393 | +1.1% | 0.10% | +17.9% |
| Q3 2015 | $403,000 | -53.7% | 12,257 | -1.5% | 0.08% | -47.2% |
| Q2 2015 | $871,000 | +15.7% | 12,449 | +13.3% | 0.16% | +3.2% |
| Q1 2015 | $753,000 | -5.0% | 10,991 | +1.6% | 0.15% | -4.9% |
| Q4 2014 | $793,000 | -7.6% | 10,816 | -9.5% | 0.16% | -16.5% |
| Q3 2014 | $858,000 | +0.9% | 11,950 | +1.6% | 0.19% | -1.0% |
| Q2 2014 | $850,000 | -16.2% | 11,763 | -14.6% | 0.20% | -21.9% |
| Q1 2014 | $1,014,000 | +19.9% | 13,780 | +13.3% | 0.25% | +14.6% |
| Q4 2013 | $846,000 | -5.5% | 12,161 | -10.7% | 0.22% | -12.4% |
| Q3 2013 | $895,000 | +12.0% | 13,617 | +18.1% | 0.25% | +16.8% |
| Q2 2013 | $799,000 | – | 11,530 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
| NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
| Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
| Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
| GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
| Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
| Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
| Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
| Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |